- Home
- MEDP vs CR Comparison
MEDP vs CR Comparison
Compare MEDP & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- CR
- Stock Information
- Founded
- MEDP 1992
- CR 1855
- Country
- MEDP United States
- CR United States
- Employees
- MEDP N/A
- CR N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- CR Metal Fabrications
- Sector
- MEDP Health Care
- CR Industrials
- Exchange
- MEDP Nasdaq
- CR Nasdaq
- Market Cap
- MEDP 10.5B
- CR 8.9B
- IPO Year
- MEDP 2016
- CR N/A
- Fundamental
- Price
- MEDP $312.74
- CR $152.08
- Analyst Decision
- MEDP Buy
- CR Strong Buy
- Analyst Count
- MEDP 10
- CR 6
- Target Price
- MEDP $373.22
- CR $174.80
- AVG Volume (30 Days)
- MEDP 384.3K
- CR 382.5K
- Earning Date
- MEDP 04-21-2025
- CR 04-21-2025
- Dividend Yield
- MEDP N/A
- CR 0.61%
- EPS Growth
- MEDP 42.23
- CR 13.55
- EPS
- MEDP 12.63
- CR 5.05
- Revenue
- MEDP $2,109,054,000.00
- CR $2,131,200,000.00
- Revenue This Year
- MEDP $4.64
- CR $9.28
- Revenue Next Year
- MEDP $9.74
- CR $6.57
- P/E Ratio
- MEDP $24.73
- CR $33.05
- Revenue Growth
- MEDP 11.84
- CR 14.45
- 52 Week Low
- MEDP $302.01
- CR $128.50
- 52 Week High
- MEDP $459.77
- CR $188.52
- Technical
- Relative Strength Index (RSI)
- MEDP 40.74
- CR 42.29
- Support Level
- MEDP $314.00
- CR $150.41
- Resistance Level
- MEDP $331.24
- CR $161.47
- Average True Range (ATR)
- MEDP 8.84
- CR 4.39
- MACD
- MEDP -0.39
- CR 0.45
- Stochastic Oscillator
- MEDP 18.32
- CR 21.87
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.